Clinical Trial

PROmega Pilot Study of Clinic-based DHA Blood Screening in Early Pregnancy

Study acronym: PROmega
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
This pilot study will explore feasibility of routine implementation of the recommended blood-based screening of DHA status in early pregnancy in routine clinical care.
Protocol Amendment History 3 changes
critical Trial status changed: Not Yet Recruiting → Enrolling by Invitation 2026-05-27
notable Primary completion pushed: 2026-08 -> 2026-12 2026-05-27
minor Completion pushed: 2027-03 -> 2027-12 2026-05-27
Trial Details
NCT Number NCT07271758
Lead Sponsor Wake Forest University Health Sciences
Conditions Nutrient Deficiency
Enrollment 650 participants
Start Date 2026-04-13
Primary Completion 2026-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2026-05-26